Ascendis Pharma A ASND
NASDAQ ASND
$270.67 -0.45 (-0.16%)
As of: Sep 4, 2026 · 3:59 PM EDT

Ascendis Pharma A (ASND) Treasury Shares (2021 - 2026)

Ascendis Pharma A (ASND) posted Treasury Shares of $1.1 million for Q4 2021.

Analysis

Ascendis Pharma A (ASND) Treasury Shares (2021 - 2026) Analysis & Trends

Ascendis Pharma A has reported Treasury Shares for 2 years, with the latest figure at -$60.7 million in Q1 2026.

  • Quarterly Treasury Shares changed N/A year-over-year to $1.1 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $1.1 million (changed N/A YoY) and the FY2021 annual result came in at $1.1 million, changed N/A from the prior year.
  • Treasury Shares retreated to -$60.7 million in Q1 2026 per ASND's latest filing, from -$18.3 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $1.1 million in Q4 2021 and troughed at $1.1 million in Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 36.40 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 2.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Ascendis Pharma A 16.39 Bn 15.45 Bn 362.22 Mn -120.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -120.20 Mn
Jun 30, 2026 -120.20 Mn
Mar 31, 2026 -60.71 Mn
Mar 31, 2026 -60.71 Mn
Jun 30, 2025 -19.69 Mn
Jun 30, 2025 -19.69 Mn
Mar 31, 2025 -18.30 Mn
Mar 31, 2025 -18.30 Mn
Dec 31, 2021 1.14 Mn
Dec 31, 2021 1.14 Mn